Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jan-Feb;91(1):101517.
doi: 10.1016/j.bjorl.2024.101517. Epub 2024 Nov 5.

Effectiveness of hypertonic saline irrigation following functional endoscopic sinus surgery: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Effectiveness of hypertonic saline irrigation following functional endoscopic sinus surgery: a systematic review and meta-analysis

Adriano Damasceno Lima et al. Braz J Otorhinolaryngol. 2025 Jan-Feb.

Abstract

Objectives: This study aimed to clarify the impact of hypertonic solutions on various outcomes, including persistence or reduction of nasal crusts, polypoid edema, and postoperative inflammatory symptoms.

Methods: We searched PubMed, Embase, and Cochrane Central Register of Controlled Trials for studies comparing hypertonic with isotonic saline irrigation after FESS in adult patients with Chronic Rhinosinusitis (CRS). Outcomes were polypoid mucosa, nasal crusts, and variation from the baseline of Sino-Nasal Outcome Test (SNOT) 20/22 and Visual Analog Scale (VAS). For statistical analysis, we used RevMan 5.4.1, and assessed heterogeneity with I2 statistics.

Results: We included a total of 479 patients from 7 studies. In the hypertonic saline group, there was a reduction in the nasal crust Risk Ratio (RR) (RR = 0.65; 95% CI 0.49 to 0.87; p = 0.004; I2 = 0%) after 30-45 days and severe crusts at 14-21 days (RR = 0.59; 95% CI 0.38 to 0.91; p = 0.02; I2 = 0%). Additionally, the persistence of polypoid mucosa was lower in the intervention arm (RR = 0.53; 95% CI 0.43 to 0.65; p < 0.00001; I2 = 0%) after 14-21 days. In the symptomatic evaluation hypertonic saline group showed an improvement in postoperative symptoms by a VAS Mean Difference (MD) (MD = -5; 95% CI -5.77 to -4.24; p < 0.00001; I2 = 0%) and a SNOT 20/22 Standard Mean Difference (SMD) (SMD = -1.65; 95% CI -2.7 to -0.61; p = 0.002; I2 = 93%) reduction from baseline in 30-45 days after the surgery.

Conclusion: Hypertonic saline showed a superior improvement in postoperative evaluation by means of nasal crusting, mucosal healing aspect, and nasal inflammatory symptoms compared with isotonic saline irrigation.

Keywords: Chronic rhinosinusitis; Meta-analysis; Nasal saline solution; Post-operative; Sinus surgery.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of study screening and selection.
Fig. 2
Fig. 2
(A) The presence of crusts was similar between the hypertonic and isotonic groups after 14‒21 days (p = 0.42). (B) The polypoidal appearance of the mucosa showed a significant risk reduction in the hypertonic solution irrigation group at 14‒21 days (p < 0.00001).
Fig. 3
Fig. 3
(A) The presence of crusts showed a significant risk reduction in the hypertonic solution irrigation group at 30‒45 postoperative days (p = 0.004). (B) The polypoidal appearance progressively improved in the hypertonic group after 30‒45 days (p < 0.00001).
Fig. 4
Fig. 4
There was a significant improvement in the presence of severe crusts in the hypertonic group after 14‒21 days (p = 0.01).
Fig. 5
Fig. 5
The visual analog scale for total nasal symptom score showed a significant reduction from baseline after 14‒21 days (p = 0.0010). The high-pressure/low-volume subgroup did not show significance; the high-volume/low-pressure group exhibited better performance by hypertonic saline in reducing the visual analog scale score.
Fig. 6
Fig. 6
The visual analog scale for total nasal symptom score, maintaining a significant reduction from baseline after 30‒45 days (p < 0.00001).
Fig. 7
Fig. 7
Sino-Nasal Outcome Test 20/22 after 30‒45 days, maintaining a significant difference compared to the isotonic solution group (p = 0.002).

References

    1. Bachert C., Holtappels G. Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14 Doc09. - PMC - PubMed
    1. Weber R.K., Hosemann W. Comprehensive review on endonasal endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14 Doc08. - PMC - PubMed
    1. Freeman S., Sivayoham E., Jepson K., de Carpentier J. A preliminary randomised controlled trial evaluating the efficacy of saline douching following endoscopic sinus surgery. Clin Otolaryngol. 2008;33:462–465. - PubMed
    1. Portela R.A., Hootnick J., McGinn J. Perioperative care in functional endoscopic sinus surgery: a survey study. Int Forum Allergy Rhinol. 2012;(2012):27–33. - PubMed
    1. Liang K., Su M., Tseng H., Jiang R. Impact of pulsatile nasal irrigation on the prognosis of functional endoscopic sinus surgery. J Otorhinolaryngol Head Neck Surg. 2008;37:148–153. - PubMed

Substances